VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $12,485,000 | -19.0% | 784,818 | +6.5% | 0.51% | -23.1% |
Q4 2017 | $15,405,000 | +1.7% | 736,718 | -30.5% | 0.67% | +16.6% |
Q3 2017 | $15,145,000 | -22.2% | 1,059,318 | -5.5% | 0.57% | -21.3% |
Q2 2017 | $19,458,000 | +46.3% | 1,121,113 | -7.2% | 0.73% | +41.4% |
Q1 2017 | $13,304,000 | -7.2% | 1,207,818 | +22.4% | 0.51% | -12.0% |
Q4 2016 | $14,332,000 | -15.5% | 987,118 | +42.6% | 0.58% | -4.3% |
Q3 2016 | $16,952,000 | +11.5% | 692,118 | -8.7% | 0.61% | +0.2% |
Q2 2016 | $15,210,000 | +31.4% | 758,300 | +72.5% | 0.61% | +33.6% |
Q1 2016 | $11,575,000 | -40.8% | 439,700 | +127.5% | 0.46% | -46.0% |
Q4 2015 | $19,560,000 | +128.7% | 193,300 | +301.5% | 0.84% | +153.0% |
Q3 2015 | $8,553,000 | -38.9% | 48,144 | -23.7% | 0.33% | -34.6% |
Q2 2015 | $14,004,000 | +148.7% | 63,100 | +121.4% | 0.51% | +197.1% |
Q1 2015 | $5,631,000 | +503.5% | 28,500 | +338.5% | 0.17% | +454.8% |
Q4 2014 | $933,000 | +72.8% | 6,500 | +58.5% | 0.03% | +14.8% |
Q1 2014 | $540,000 | -95.7% | 4,100 | -96.2% | 0.03% | -95.8% |
Q4 2013 | $12,491,000 | -22.1% | 106,500 | -30.6% | 0.64% | -28.7% |
Q3 2013 | $16,039,000 | +106.6% | 153,500 | +70.0% | 0.90% | +75.9% |
Q2 2013 | $7,762,000 | – | 90,300 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |